Payment overview · 2025
General Payments
$138.99
7 reported records · 5 companies
Healthcare provider profile · identity verified
Brian Keith Adler, MD
Allopathic & Osteopathic Physicians|Internal Medicine · MYRTLE BEACH, SC · NPI 1801810007
Verified facts
What the public records show
CMS Open Payments records show Brian Keith Adler, MD received $138.99 in general payments during 2025 across 7 reported records.
Exact Sciences Corporation accounted for 25.6% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 6 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Jardiance.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 47708 records involving 23833 distinct recipient NPIs. Public Medicare Part D data also shows 29 claims for Jardiance by this doctor in 2024.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported MOUNJARO as an associated drug or biological on 186719 records involving 66436 distinct recipient NPIs. Public Medicare Part D data also shows 25 claims for Mounjaro by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $35.61 | 25.6% | 2 | 2025 |
| Amgen Inc. | Unresolved — no canonical attribution shown | $31.42 | 22.6% | 2 | 2025 |
| Lilly USA, LLC | Unresolved — no canonical attribution shown | $25.64 | 18.4% | 1 | 2025 |
| Braeburn Inc. | Unresolved — no canonical attribution shown | $25.12 | 18.1% | 1 | 2025 |
| Indivior Inc. | Unresolved — no canonical attribution shown | $21.20 | 15.2% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $138.99 | 7 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Cologuard Collection Kit Normalized: cologuard collection kit |
Device | Exact Sciences Corporation | $35.61 | 2 | 2025 |
Source payment records
|
|||||
| OTEZLA Normalized: otezla |
Drug | Amgen Inc. | $31.42 | 2 | 2025 |
Source payment records
|
|||||
| REPATHA Normalized: repatha |
Biological | Amgen Inc. | $31.42 | 2 | 2025 |
Source payment records
|
|||||
| JARDIANCE Normalized: jardiance |
Drug | Lilly USA, LLC | $25.64 | 1 | 2025 |
Source payment records
|
|||||
| BRIXADI Normalized: brixadi |
Drug | Braeburn Inc. | $25.12 | 1 | 2025 |
Source payment records
|
|||||
| SUBLOCADE Normalized: sublocade |
Drug | Indivior Inc. | $21.20 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| JARDIANCE jardiance |
2025 | Jardiance | 2024 | 29 Beneficiary count suppressed |
exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | JARDIANCE open payments reported associated product |
CMS Open Payments — General Payments 47708 supporting records · 23833 recipient NPIs · example record 1186464557 |
Jardiance · 2024 Exact normalized brand match · 1 Part D row |
29 | suppressed by CMS |
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | MOUNJARO open payments reported associated product |
CMS Open Payments — General Payments 186719 supporting records · 66436 recipient NPIs · example record 1186464455 |
Mounjaro · 2024 Exact normalized brand match · 1 Part D row |
25 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 950 | 299 |
| Levothyroxine Sodium | Levothyroxine Sodium | 808 | 235 |
| Simvastatin | Simvastatin | 576 | 169 |
| Amlodipine Besylate | Amlodipine Besylate | 539 | 172 |
| Losartan Potassium | Losartan Potassium | 492 | 161 |
| Metformin Hcl | Metformin Hcl | 452 | 147 |
| Lisinopril | Lisinopril | 446 | 134 |
| Omeprazole | Omeprazole | 405 | 127 |
| Pantoprazole Sodium | Pantoprazole Sodium | 351 | 120 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 319 | 107 |
| Prednisone | Prednisone | 281 | 193 |
| Alprazolam | Alprazolam | 271 | 52 |
| Montelukast Sodium | Montelukast Sodium | 251 | 87 |
| Metoprolol Succinate | Metoprolol Succinate | 248 | 73 |
| Gabapentin | Gabapentin | 244 | 88 |
| Hydrochlorothiazide | Hydrochlorothiazide | 229 | 76 |
| Metoprolol Tartrate | Metoprolol Tartrate | 215 | 73 |
| Glipizide | Glipizide | 208 | 69 |
| Zolpidem Tartrate | Zolpidem Tartrate | 205 | 34 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 199 | 75 |
| Tamsulosin Hcl | Tamsulosin Hcl | 197 | 66 |
| Pravastatin Sodium | Pravastatin Sodium | 184 | 55 |
| Allopurinol | Allopurinol | 178 | 55 |
| Pioglitazone Hcl | Pioglitazone Hcl | 177 | 62 |
| Trazodone Hcl | Trazodone Hcl | 173 | 53 |
| Tramadol Hcl | Tramadol Hcl | 160 | 51 |
| Clopidogrel | Clopidogrel Bisulfate | 158 | 54 |
| Sertraline Hcl | Sertraline Hcl | 153 | 43 |
| Fluticasone Propionate | Fluticasone Propionate | 144 | 65 |
| Ezetimibe | Ezetimibe | 138 | 49 |
| Citalopram Hbr | Citalopram Hydrobromide | 134 | 44 |
| Furosemide | Furosemide | 132 | 51 |
| Ozempic | Semaglutide | 131 | 39 |
| Buprenorphine-Naloxone | Buprenorphine Hcl/Naloxone Hcl | 125 | 15 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 125 | 35 |
| Atenolol | Atenolol | 124 | 35 |
| Clonazepam | Clonazepam | 123 | 17 |
| Escitalopram Oxalate | Escitalopram Oxalate | 120 | 34 |
| Eliquis | Apixaban | 108 | 32 |
| Lorazepam | Lorazepam | 107 | 18 |
| Carvedilol | Carvedilol | 105 | 36 |
| Synthroid | Levothyroxine Sodium | 101 | 30 |
| Buspirone Hcl | Buspirone Hcl | 93 | 32 |
| Ibuprofen | Ibuprofen | 91 | 34 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 91 | 29 |
| Duloxetine Hcl | Duloxetine Hcl | 82 | 24 |
| Buprenorphine Hcl | Buprenorphine Hcl | 80 | suppressed |
| Cefuroxime | Cefuroxime Axetil | 79 | 64 |
| Celecoxib | Celecoxib | 77 | 26 |
| Hydralazine Hcl | Hydralazine Hcl | 71 | 24 |
| Donepezil Hcl | Donepezil Hcl | 70 | 26 |
| Lovastatin | Lovastatin | 70 | 19 |
| Oxybutynin Chloride | Oxybutynin Chloride | 69 | 18 |
| Azithromycin | Azithromycin | 68 | 58 |
| Labetalol Hcl | Labetalol Hcl | 66 | 20 |
| Finasteride | Finasteride | 65 | 19 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 64 | 17 |
| Amitriptyline Hcl | Amitriptyline Hcl | 63 | 20 |
| Xarelto | Rivaroxaban | 62 | 15 |
| Meloxicam | Meloxicam | 61 | 22 |
| Spironolactone | Spironolactone | 61 | 25 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 58 | 22 |
| Doxycycline Hyclate | Doxycycline Hyclate | 57 | 48 |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 57 | 17 |
| Meclizine Hcl | Meclizine Hcl | 55 | 29 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 51 | 15 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 51 | 26 |
| Farxiga | Dapagliflozin Propanediol | 51 | 18 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 50 | 16 |
| Metformin Hcl Er | Metformin Hcl | 49 | 15 |
| Januvia | Sitagliptin Phosphate | 48 | 13 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 47 | 15 |
| Diazepam | Diazepam | 46 | 12 |
| Paroxetine Hcl | Paroxetine Hcl | 46 | 15 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 46 | 38 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 46 | 12 |
| Bupropion Xl | Bupropion Hcl | 45 | 14 |
| Fluoxetine Hcl | Fluoxetine Hcl | 45 | 15 |
| Mirtazapine | Mirtazapine | 43 | 15 |
| Potassium Chloride | Potassium Chloride | 42 | 15 |
| Fenofibrate | Fenofibrate Nanocrystallized | 41 | 14 |
| Dicyclomine Hcl | Dicyclomine Hcl | 39 | 20 |
| Quetiapine Fumarate | Quetiapine Fumarate | 38 | 14 |
| Estradiol | Estradiol | 37 | 15 |
| Famotidine | Famotidine | 37 | 14 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 37 | 14 |
| Pregabalin | Pregabalin | 37 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 37 | 13 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 36 | 17 |
| Valsartan | Valsartan | 36 | 14 |
| Valacyclovir | Valacyclovir Hcl | 35 | 18 |
| Benazepril Hcl | Benazepril Hcl | 34 | suppressed |
| Glimepiride | Glimepiride | 34 | suppressed |
| Nifedipine Er | Nifedipine | 34 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 33 | 14 |
| Breo Ellipta | Fluticasone/Vilanterol | 32 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 32 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 32 | 14 |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 31 | suppressed |
| Gemfibrozil | Gemfibrozil | 31 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 31 | 11 |
| Jardiance | Empagliflozin | 29 | suppressed |
| Glipizide Er | Glipizide | 28 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 28 | suppressed |
| Nystatin | Nystatin | 27 | 11 |
| Promethazine Hcl | Promethazine Hcl | 26 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 26 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 25 | suppressed |
| Fenofibrate | Fenofibrate | 25 | 11 |
| Mounjaro | Tirzepatide | 25 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 25 | 25 |
| Tizanidine Hcl | Tizanidine Hcl | 25 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 24 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 24 | 22 |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 24 | suppressed |
| Cephalexin | Cephalexin | 23 | 20 |
| Lansoprazole | Lansoprazole | 23 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 23 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 22 | suppressed |
| Glyburide | Glyburide | 22 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 22 | suppressed |
| Irbesartan | Irbesartan | 21 | suppressed |
| Lamotrigine | Lamotrigine | 21 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 21 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 20 | 15 |
| Janumet | Sitagliptin Phos/Metformin Hcl | 20 | suppressed |
| Linzess | Linaclotide | 20 | suppressed |
| Suboxone | Buprenorphine Hcl/Naloxone Hcl | 20 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 20 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 19 | suppressed |
| Colchicine | Colchicine | 19 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 19 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 19 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 19 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 18 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 18 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 18 | suppressed |
| Chlorthalidone | Chlorthalidone | 17 | suppressed |
| Fluconazole | Fluconazole | 17 | 14 |
| Myrbetriq | Mirabegron | 17 | suppressed |
| Verapamil Er | Verapamil Hcl | 17 | suppressed |
| Acyclovir | Acyclovir | 16 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 16 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 16 | suppressed |
| Memantine Hcl | Memantine Hcl | 16 | suppressed |
| Methotrexate | Methotrexate Sodium | 16 | suppressed |
| Minoxidil | Minoxidil | 16 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 16 | suppressed |
| Varenicline Tartrate | Varenicline Tartrate | 16 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 16 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 15 | suppressed |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 15 | suppressed |
| Methimazole | Methimazole | 15 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 15 | 13 |
| Amoxicillin | Amoxicillin | 14 | 14 |
| Cilostazol | Cilostazol | 14 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 14 | suppressed |
| Telmisartan | Telmisartan | 14 | suppressed |
| Amlodipine-Olmesartan | Amlodipine Bes/Olmesartan Med | 13 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 13 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 13 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 13 | suppressed |
| Icosapent Ethyl | Icosapent Ethyl | 13 | suppressed |
| Ketoconazole | Ketoconazole | 13 | 11 |
| Ramipril | Ramipril | 13 | suppressed |
| Soliqua 100-33 | Insulin Glargine/Lixisenatide | 13 | suppressed |
| Temazepam | Temazepam | 13 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 13 | suppressed |
| Zubsolv | Buprenorphine Hcl/Naloxone Hcl | 13 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 12 | suppressed |
| Cozaar | Losartan Potassium | 12 | suppressed |
| Prochlorperazine Maleate | Prochlorperazine Maleate | 12 | suppressed |
| Topiramate | Topiramate | 12 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 12 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 12 | suppressed |
| Alprazolam Odt | Alprazolam | 11 | suppressed |
| Baclofen | Baclofen | 11 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 11 | 11 |
| Fluocinonide | Fluocinonide | 11 | suppressed |
| Levetiracetam | Levetiracetam | 11 | suppressed |
| Naproxen | Naproxen | 11 | suppressed |
| Pitavastatin Calcium | Pitavastatin Calcium | 11 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $138.99 · 7 records | Exact Sciences Corporation | BRIXADI, Cologuard Collection Kit, JARDIANCE, OTEZLA, REPATHA, SUBLOCADE | 2 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Jardiance play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with Lilly USA, LLC?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error